Rituximab-resistant chimeric antigen receptors and uses thereof

PH12021552415B1Active Publication Date: 2026-11-06ALLOGENE THERAPEUTICS INC
0 Cites 0 Cited by

Patent Information

Application Number
PH12021552415
Authority / Receiving Office
PH · PH
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-09-28
Publication Date
2026-11-06
Estimated Expiration
2041-09-28
Patent Text Reader

Abstract

Provided herein are polynucleotides encoding chimeric antigen receptors (CARs) comprising a CD19 antigen binding domain that specifically binds to CD19 and is resistant to rituximab binding; and immune cells comprising these CD19-specific CARs, e.g., CAR-T cells. Also provided are methods of making and using these CD19-specific CARs, and immune cells comprising these CD19-specific CARs.
Need to check novelty before this filing date? Find Prior Art